News

Intermountain Health patient first to be treated with external bioengineered liver
The patient treated with the miroliverELAP is experiencing liver failure, but was not eligible for a transplant, a statement ...
Melatonin doses can vary from what’s on the label. Here’s how much.
An FDA study of 110 melatonin supplements marketed for children found doses ranged from 0 to 667 percent of the amount on the ...
United Therapeutics Announces World’s First Bioengineered External Liver Treatment in Clinical Study
United Therapeutics Corporation (NASDAQ: UTHR) is one of the most undervalued US stocks according to analysts. On June 24, ...
StockStory.org on MSN6d
5 Must-Read Analyst Questions From United Therapeutics’s Q1 Earnings Call
United Therapeutics’ first quarter results came in above Wall Street’s expectations, but the market reacted negatively, with ...
Morningstar5d
UTHR - United Therapeutics Corp Valuation - Morningstar
Review the current valuation for United Therapeutics Corp (UTHR:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.
Regenerative Medicine Market Set to Reach Valuation of US$ 578.59 Billion By 2033 | Astute Analytica
Regenerative medicine market accelerates as aging populations and reimbursement shifts raise demand. AI-guided gene editing, ...
Regenerative Medicine Market to Reach $45.66 Billion by 2032, Growing at a CAGR of 22.0% from 2025, Says Meticulous Research®
The growth of the regenerative medicine market is driven by factors such as increasing approvals for regenerative medicine, ...